[HTML][HTML] Immunosenescence: a key player in cancer development

J Lian, Y Yue, W Yu, Y Zhang - Journal of hematology & oncology, 2020 - Springer
Immunosenescence is a process of immune dysfunction that occurs with age and includes
remodeling of lymphoid organs, leading to changes in the immune function of the elderly …

[HTML][HTML] State of the art in combination immuno/radiotherapy for brain metastases: systematic review and meta-analysis

M Najafi, A Jahanbakhshi, M Gomar, C Iotti… - Current …, 2022 - mdpi.com
Objectives: Common origins for brain metastases (BMs) are melanoma, lung, breast, and
renal cell cancers. BMs account for a large share of morbidity and mortality caused by these …

Safety and clinical efficacy of immune checkpoint inhibition and stereotactic body radiotherapy in patients with spine metastasis

E Lee, X Chen, MC LeCompte, LR Kleinberg… - … of Neurosurgery: Spine, 2023 - thejns.org
OBJECTIVE Immunotherapy, particularly immune checkpoint inhibitors (ICIs), has
revolutionized the treatment of patients with many tumor histologies. Simultaneously …

Advances in radiotherapy in bone metastases in the context of new target therapies and ablative alternatives: A critical review

AG Gouveia, DCW Chan, PJ Hoskin, GN Marta… - Radiotherapy and …, 2021 - Elsevier
In patients with bone metastases (BM), radiotherapy (RT) is used to alleviate symptoms,
reduce the risk of fracture, and improve quality of life (QoL). However, with the emergence of …

[HTML][HTML] Efficacy and safety of CyberKnife radiosurgery in elderly patients with brain metastases: a retrospective clinical evaluation

G Acker, SM Hashemi, J Fuellhase, A Kluge, A Conti… - Radiation …, 2020 - Springer
Background Stereotactic radiosurgery (SRS) has been increasingly applied for up to 10
brain metastases instead of whole brain radiation therapy (WBRT) to achieve local tumor …

Radiotherapy for non-Hodgkin lymphomas

BS Imber, J Yahalom - The Cancer Journal, 2020 - journals.lww.com
Radiotherapy (RT) plays a diverse and essential role in the contemporary management of
non-Hodgkin lymphoma (NHL) and remains the single most powerful monotherapeutic …

Targeting programmed cell death protein 1 (PD-1) for treatment of non-small-cell lung carcinoma (NSCLC); the recent advances

T Dehghani, A Shahrjerdi, MS Kahrizi… - … -Research and Practice, 2023 - Elsevier
The immune system uses various immune checkpoint axes to adjust responses, support
homeostasis, and deter self-reactivity and autoimmunity. Nevertheless, non-small-cell lung …

[HTML][HTML] Theranostic nanoparticles enhance the response of glioblastomas to radiation

W Wu, JL Klockow, S Mohanty, KS Ku, M Aghighi… - …, 2019 - ncbi.nlm.nih.gov
Despite considerable progress with our understanding of glioblastoma multiforme (GBM)
and the precise delivery of radiotherapy, the prognosis for GBM patients is still unfavorable …

SBRT for elderly oligometastatic patients as a feasible, safe and effective treatment opportunity

F Cuccia, R Mazzola, E Pastorello, V Figlia… - Clinical & Experimental …, 2021 - Springer
The constantly increasing life expectancy is raising the issue of treating oncological older
patients, who were traditionally candidates to best supportive care or palliative treatments …

[PDF][PDF] Non-stereotactic radiotherapy in older cancer patients

S Parisi, S Lillo, A Cacciola, G Ferini, V Valenti, A Viola… - Heliyon, 2022 - cell.com
Old or very old oncological patients represent a heterogeneous and frail population due to
concomitant comorbidities. Whether radiotherapy alone or in combination with novel cancer …